Hepatocyte growth factor in patients with coronary artery disease and its relation to periodontal condition

Results in Immunology

Volumn 2, Issue , 2012, Pages 7-12

  Lonn J ^a,b   Starkhammar Johansson, C ^c   Kalvegren H ^c   Brudin, L ^d   Skoglund, C ^c   Garvin, P ^c   Sarndahl E ^a,e   Ravald, N ^c   Richter, A ^d   Bengtsson, T ^a   Nayeri, F ^b,d  

^a ÖREBRO UNIVERSITY   (Sweden)

^b PEAS Institute   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiography; Coronary artery disease; Hepatocyte growth factor; Periodontal disease; Porphyromonas gingivalis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; PROTEOHEPARAN SULFATE; SCATTER FACTOR;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; LOADING DRUG DOSE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTITIS; PERIODONTIUM; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; UNSTABLE ANGINA PECTORIS;

EID: 84855719213     PISSN: None     EISSN: 22112839     Source Type: Journal    
DOI: 10.1016/j.rinim.2011.12.002     Document Type: Article

References (42)

1. Aoki M., Morishita R., Taniyama Y., Kaneda Y., Ogihara T. Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases. Journal of Atherosclerosis and Thrombosis 2000, 7:71-76.
2. Nakamura T., Mizuno S., Matsumoto K., Sawa Y., Matsuda H. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. Journal of Clinical Investigation 2000, 106:1511-1519.
3. Van Belle E., Witzenbichler B., Chen D., Silver M., Chang L., Schwall R., et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998, 97:381-390.
4. McKinnon H., Gherardi E., Reidy M., Bowyer D. Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis. American Journal of Pathology 2006, 168:340-348.
5. Nakamura T., Sakai K., Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. Journal of Gastroenterology and Hepatology 2011, 26(Suppl. 1):188-202.
6. Liu K.X., Kato Y., Narukawa M., Kim D.C., Hanano M., Higuchi O., et al. Importance of the liver in plasma clearance of hepatocyte growth factors in rats. American Journal of Physiology 1992, 263:G642-G649.
7. Nakamura T., Teramoto H., Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proceedings of the National Academy of Sciences of United States of America 1986, 83:6489-6493.
8. Karihaloo A., Kale S., Rosenblum N.D., Cantley L.G. Hepatocyte growth factor-mediated renal epithelial branching morphogenesis is regulated by glypican-4 expression. Molecular and Cellular Biology 2004, 24:8745-8752.
9. Rubin J.S., Day R.M., Breckenridge D., Atabey N., Taylor W.G., Stahl S.J., et al. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling. Journal of Biological Chemistry 2001, 276:32977-32983.
10. Sakata H., Stahl S.J., Taylor W.G., Rosenberg J.M., Sakaguchi K., Wingfield P.T., et al. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. Journal of Biological Chemistry 1997, 272:9457-9463.
11. Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. Journal of Biological Chemistry 1993, 268:10024-10028.
12. Nayeri F., Olsson H., Peterson C., Sundqvist T. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers. Journal of Dermatological Science 2005, 37:75-85.
13. Funakoshi H., Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clinica Chimica Acta 2003, 327:1-23.
14. Nayeri F., Holmgren-Pettersson K., Perskvist N., Forsberg P., Peterson C., Sundqvist T. An in vitro model for assessment of the biological activity of hepatocyte growth factor. Growth Factors 2007, 25:33-40.
15. Yaekashiwa M., Nakayama S., Ohnuma K., Sakai T., Abe T., Satoh K., et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. American Journal of Respiratory and Critical Care Medicine 1997, 156:1937-1944.
16. Ueki T., Kaneda Y., Tsutsui H., Nakanishi K., Sawa Y., Morishita R., et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Medicine 1999, 5:226-230.
17. Mizuno S., Kurosawa T., Matsumoto K., Mizuno-Horikawa Y., Okamoto M., Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. Journal of Clinical Investigation 1998, 101:1827-1834.
18. Nishimura M., Ushiyama M., Ohtsuka K., Nishida M., Inoue N., Matsumuro A., et al. Serum hepatocyte growth factor as a possible indicator of vascular lesions. Journal of Clinical Endocrinology and Metabolism 1999, 84:2475-2480.
19. Susen S., Sautière K., Mouquet F., Cuilleret F., Chmaït A., McFadden E.P., et al. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization. European Heart Journal 2005, 26:2387-2395.
20. Liu Y., Wilkinson F.L., Kirton J.P., Jeziorska M., Iizasa H., Sai Y., et al. Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development. Journal of Pathology 2007, 212:12-19.
21. Starkhammar Johansson C., Richter A., Lundström A., Thorstensson H., Ravald N. Periodontal conditions in patients with coronary heart disease: a case-control study. Journal of Clinical Periodontology 2008, 35:199-205.
22. Bahekar A.A., Singh S., Saha S., Molnar J., Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. American Heart Journal 2007, 154:830-837.
23. Petersen P.E., Ogawa H. Strengthening the prevention of periodontal disease: the WHO approach. Journal of Periodontology 2005, 76:2187-2193.
24. Haraszthy V.I., Zambon J.J., Trevisan M., Zeid M., Genco R.J. Identification of periodontal pathogens in atheromatous plaques. Journal of Periodontology 2000, 71:1554-1560.
25. Pussinen P.J., Alfthan G., Tuomilehto J., Asikainen S., Jousilahti P. High serum antibody levels to Porphyromonas gingivalis predict myocardial infarction. European Journal of Cardiovascular Prevention and Rehabilitation 2004, 11:408-411.
26. Renvert S., Pettersson T., Ohlsson O., Persson G.R. Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome. Journal of Periodontology 2006, 77:1110-1119.
27. Goulet V., Britigan B., Nakayama K., Grenier D. Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals. Infection and Immunity 2004, 72:4351-4356.
28. Nagaraja C., Pradeep A.R. Hepatocyte growth factor levels in gingival crevicular fluid in health, disease, and after treatment. Journal of Periodontology 2007, 78:742-747.
29. Sugiyama A., Ogawa T., Daikuhara Y., Takada H. Enhancement of hepatocyte growth factor (scatter factor) production by human gingival fibroblasts in culture stimulated with Porphyromonas gingivalis fimbriae. Journal of Medical Microbiology 2000, 49:319-325.
30. Nayeri F., Nayeri T., Aili D., Brudin L., Liedberg B. Clinical impact of real-time evaluation of the biological activity and degradation of hepatocyte growth factor. Growth Factors 2008, 26:163-171.
31. Nayeri F., Strömberg T., Larsson M., Brudin L., Söderström C., Forsberg P. Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study. Journal of Dermatological Treatment 2002, 13:81-86.
32. Liedberg B., Nylander C., Lundström I. Biosensing with surface plasmon resonance-how it all started. Biosensors and Bioelectronics 1995, 10:i-ix.
33. Nayeri F., Aili D., Nayeri T., Xu J., Almer S., Lundström I., et al. Hepatocyte growth factor (HGF) in fecal samples: rapid detection by surface plasmon resonance. BMC Gastroenterology 2005, 5:13.
34. Garvin P., Nilsson L., Carstensen J., Jonasson L., Kristenson M. Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population. PLoS One 2008, 3:e1774.
35. Lindhe J., Nyman S. The effect of plaque control and surgical pocket elimination on the establishment and maintenance of periodontal health. A longitudinal study of periodontal therapy in cases of advanced disease. Journal of Clinical Periodontology 1975, 2:67-79.
36. Hugoson A., Jordan T. Frequency distribution of individuals aged 20-70 years according to severity of periodontal disease. Community Dentistry and Oral Epidemiology 1982, 10:187-192.
37. Slots J., Ashimoto A., Flynn M.J., Li G., Chen C. Detection of putative periodontal pathogens in subgingival specimens by 16S ribosomal DNA amplification with the polymerase chain reaction. Clinical Infectious Diseases 1995, 20(Suppl. 2):S304-S307.
38. Rescan P.Y., Loréal O., Hassell J.R., Yamada Y., Guillouzo A., Clément B. Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture. American Journal of Pathology 1993, 142:199-208.
39. Schlessinger J., Lax I., Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?. Cell 1995, 83:357-360.
40. Liu K.X., Kato Y., Kato M., Kaku T.I., Nakamura T., Sugiyama Y. Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats. American Journal of Physiology 1997, 273:E891-E897.
41. Wang N., Tong G., Yang J., Zhou Z., Pan H., Huo Y., et al. Effect of hepatocyte growth-promoting factors on myocardial ischemia during exercise in patients with severe coronary artery disease. International Heart Journal 2009, 50:291-299.
42. Urbanek K., Rota M., Cascapera S., Bearzi C., Nascimbene A., De Angelis A., et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circulation Research 2005, 97:663-673.